You are here

Lyell Immunopharma

No regrets as Lyell prepares for its first clinical trial

EP Vantage

Mon, 02/7/22 - 11:13 am

Lyell Immunopharma

clinical trials

Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs

MedCity News

Fri, 12/31/21 - 11:04 am

artificial intelligence

Sana Biotechnology

Lyell Immunopharma

Caribou Biosciences

Talaris Therapeutics

Achilles Therapeutics

Biotech listings shows few signs of cooling

EP Vantage

Fri, 07/2/21 - 10:53 am

Lyell Immunopharma

Recursion Pharmaceuticals

Centessa Pharmaceuticals

Verve Therapeutics

Another four IPOs complete busy week as biotech raise continues to match 2020's record pace

Endpoints

Fri, 06/18/21 - 10:06 am

Lyell Immunopharma

Verve Therapeutics

Molecular Partners

ATAI Life Sciences

Century Therapeutics

Cyteir Therapeutics

GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO

Fierce Biotech

Wed, 05/26/21 - 11:16 am

Lyell Immunopharma

Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors

Fierce Biotech

Wed, 09/2/20 - 11:13 am

Lyell Immunopharma